IBDEI23Z ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35763,2)
 ;;=^5011790
 ;;^UTILITY(U,$J,358.3,35764,0)
 ;;=M35.00^^134^1730^59
 ;;^UTILITY(U,$J,358.3,35764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35764,1,3,0)
 ;;=3^Sicca Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,35764,1,4,0)
 ;;=4^M35.00
 ;;^UTILITY(U,$J,358.3,35764,2)
 ;;=^5011786
 ;;^UTILITY(U,$J,358.3,35765,0)
 ;;=M32.10^^134^1730^62
 ;;^UTILITY(U,$J,358.3,35765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35765,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec Organ/System Involvement
 ;;^UTILITY(U,$J,358.3,35765,1,4,0)
 ;;=4^M32.10
 ;;^UTILITY(U,$J,358.3,35765,2)
 ;;=^5011753
 ;;^UTILITY(U,$J,358.3,35766,0)
 ;;=M32.9^^134^1730^61
 ;;^UTILITY(U,$J,358.3,35766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35766,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec
 ;;^UTILITY(U,$J,358.3,35766,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,35766,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,35767,0)
 ;;=M34.2^^134^1730^63
 ;;^UTILITY(U,$J,358.3,35767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35767,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
 ;;^UTILITY(U,$J,358.3,35767,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,35767,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,35768,0)
 ;;=M34.81^^134^1730^64
 ;;^UTILITY(U,$J,358.3,35768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35768,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,35768,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,35768,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,35769,0)
 ;;=M34.82^^134^1730^65
 ;;^UTILITY(U,$J,358.3,35769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35769,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,35769,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,35769,2)
 ;;=^5011782
 ;;^UTILITY(U,$J,358.3,35770,0)
 ;;=M34.83^^134^1730^66
 ;;^UTILITY(U,$J,358.3,35770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35770,1,3,0)
 ;;=3^Systemic Sclerosis w/ Polyneuropathy
 ;;^UTILITY(U,$J,358.3,35770,1,4,0)
 ;;=4^M34.83
 ;;^UTILITY(U,$J,358.3,35770,2)
 ;;=^5011783
 ;;^UTILITY(U,$J,358.3,35771,0)
 ;;=M34.9^^134^1730^67
 ;;^UTILITY(U,$J,358.3,35771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35771,1,3,0)
 ;;=3^Systemic Sclerosis,Unspec
 ;;^UTILITY(U,$J,358.3,35771,1,4,0)
 ;;=4^M34.9
 ;;^UTILITY(U,$J,358.3,35771,2)
 ;;=^5011785
 ;;^UTILITY(U,$J,358.3,35772,0)
 ;;=M81.0^^134^1731^18
 ;;^UTILITY(U,$J,358.3,35772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35772,1,3,0)
 ;;=3^Osteoporosis,Age-Related
 ;;^UTILITY(U,$J,358.3,35772,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,35772,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,35773,0)
 ;;=M46.46^^134^1731^2
 ;;^UTILITY(U,$J,358.3,35773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35773,1,3,0)
 ;;=3^Discitis,Lumbar Region,Unspec
 ;;^UTILITY(U,$J,358.3,35773,1,4,0)
 ;;=4^M46.46
 ;;^UTILITY(U,$J,358.3,35773,2)
 ;;=^5012006
 ;;^UTILITY(U,$J,358.3,35774,0)
 ;;=M46.47^^134^1731^3
 ;;^UTILITY(U,$J,358.3,35774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35774,1,3,0)
 ;;=3^Discitis,Lumbosacral Region,Unspec
 ;;^UTILITY(U,$J,358.3,35774,1,4,0)
 ;;=4^M46.47
 ;;^UTILITY(U,$J,358.3,35774,2)
 ;;=^5012007
 ;;^UTILITY(U,$J,358.3,35775,0)
 ;;=J98.6^^134^1731^1
 ;;^UTILITY(U,$J,358.3,35775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35775,1,3,0)
 ;;=3^Diaphragm Disorders
 ;;^UTILITY(U,$J,358.3,35775,1,4,0)
 ;;=4^J98.6
 ;;^UTILITY(U,$J,358.3,35775,2)
 ;;=^5008364
 ;;^UTILITY(U,$J,358.3,35776,0)
 ;;=M54.9^^134^1731^5
 ;;^UTILITY(U,$J,358.3,35776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35776,1,3,0)
 ;;=3^Dorsalgia,Unspec
 ;;^UTILITY(U,$J,358.3,35776,1,4,0)
 ;;=4^M54.9
